Rocket


News + Filings
Holdings





All
13F
13D/G
Other


Western Standard LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 SC 13D/A Western Standard LLC reports a 13.9% stake in Merrimack Pharmaceuticals, Inc.
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/09/2023 4 Andersen Eric (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns: Bought 84,636 shares @ $12.0037, valued at $1M
Bought 49,857 shares @ $12.0037, valued at $598.5k
Bought 68,431 shares @ $11.9959, valued at $820.9k
Bought 18,626 shares @ $11.9959, valued at $223.4k
05/15/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
03/22/2023 4 Andersen Eric (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns: Bought 127,409 shares @ $11.52, valued at $1.5M
Bought 33,181 shares @ $11.52, valued at $382.2k
03/01/2023 4/A Andersen Eric (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns: Bought 19,750 shares @ $11.3576, valued at $224.3k
Bought 4,985 shares @ $11.3576, valued at $56.6k
Bought 1,782 shares @ $11.3998, valued at $20.3k
Bought 450 shares @ $11.3998, valued at $5.1k
02/15/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2023 4 Andersen Eric (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns: Bought 17,465 shares @ $11.3965, valued at $199k
Bought 4,410 shares @ $11.3965, valued at $50.3k
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/28/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/15/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/16/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/16/2022 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
02/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/15/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
09/20/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
08/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/03/2021 SC 13G Western Standard LLC reports a 6.7% stake in Marlin Business Services Corp.
05/17/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
04/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/27/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2020 4 Andersen Eric (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns: Bought 1,959 shares @ $3.65, valued at $7.2k
Bought 54,531 shares @ $3.65, valued at $199k
11/16/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/17/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/14/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 SC 13D/A Western Standard LLC reports a 7.8% stake in Merrimack Pharmaceuticals, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy